Alnylam Pharma(CH:DUL)
CHFÂ 138.580.00 (0.00%)
CH:DUL
Alnylam Pharma earnings date
CHFÂ 138.58
At close:0.00 (0.00%)
Alnylam Pharma (DUL) Q1 2025 Earnings Report
0 Followers
CH:DUL Q1 2025 EPS Results
- Actual EPS
- -CHF 0.37
- Consensus EPS
- -CHF 0.75
- Beat/Miss
- Beat by +CHF 0.38
- One Year Ago EPS
- -CHF 0.44
CH:DUL Q1 2025 Revenue Results
- Actual Revenue
- CHF 498.60M
- Expected Revenue
- CHF 491.01M
- Beat/Miss
- Beat by +CHF 7.59M
- YoY Revenue Growth
- +20.20%
Earnings Announcement Details
- Quarter
- Q1 2025
- Date
- 05/01/2025
- Time
- Before Open
- Conference Call
- Thursday, May 1, 2025
CH:DUL Upcoming Earnings
Alnylam Pharma's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q1 2025 Earnings Call Audio
CH:DUL Q1 2025 Earnings Call
0:00 / 0:00
Q1 2025 Earnings Slide Deck
Q1 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:DUL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 1.44- | 0.69 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 1.3913.19 | 1.54 | 754.35% (+11.65) | |
| Jul 30, 2026 | 2026 (Q2) | 1.371.02 | -0.43 | 337.25% (+1.44) | |
| Apr 30, 2026 | 2026 (Q1) | 0.731.27 | -0.37 | 443.18% (+1.64) | |
| Feb 12, 2026 | 2025 (Q4) | 0.970.69 | -0.55 | 226.15% (+1.23) | |
| Oct 30, 2025 | 2025 (Q3) | 0.471.54 | -0.73 | 311.49% (+2.27) | |
| Jul 31, 2025 | 2025 (Q2) | -0.46-0.43 | -0.11 | -292.31% (-0.32) | |
| May 01, 2025 | 2025 (Q1) | -0.75-0.37 | -0.44 | 15.38% (+0.07) | |
| Feb 13, 2025 | 2024 (Q4) | -0.50-0.55 | -0.92 | 40.91% (+0.38) | |
| Oct 31, 2024 | 2024 (Q3) | -0.77-0.73 | 0.97 | -175.65% (-1.70) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


